Scent

Ferrara, Italy Founded: 2015 • Age: 11 yrs
Screening device for colorectal adenomas
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Scent

Scent is a company based in Ferrara (Italy) founded in 2015. Scent operates in a competitive market with competitors including IGM Biosciences, Check-Cap, New Element Medicine, Zymedi and Brenus Pharma, among others.

  • Headquarter Ferrara, Italy
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Scent

Investors in Scent

Scent has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include UniCredit Start Lab.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Premium access

Investor details for Scent

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Scent

Investments
Premium access

Investment portfolio details for Scent

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Scent

Premium access

Detailed financials for Scent

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Scent Comparisons

Scent Primary company
Description
Screening device for colorectal adenomas
Location
Ferrara, Italy
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Scent

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Scent

Scent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IGM Biosciences, Check-Cap, New Element Medicine, Zymedi and Brenus Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Antibodies for cancer and infectious disease treatments are developed.
Locked Locked Locked
Developer of imaging capsules for colorectal cancer screening
Locked Locked Locked
Drugs for cancer and metabolic diseases are developed.
Locked Locked Locked
Therapeutics for multiple diseases are developed using Aminoacyl-tRNA Synthetase technology.
Locked Locked Locked
Immunotherapy for cancer treatment is developed by Brenus Pharma.
Locked Locked Locked
Non-invasive diagnostics for colorectal cancer screening are developed.
Premium access

Detailed competitors of Scent

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Scent

Premium access

Complete news archive for Scent

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Scent

Scent was founded in 2015.

Scent is headquartered in Ferrara, Italy. It is registered at Ferrara, Emilia-romagna, Italy.

Scent was established in 2015 as a spin-out from the University of Ferrara in Italy. The company focuses on medical devices within the biotechnology sector, specifically developing the SCENT A1 prototype for colorectal adenoma screening. This portable tool analyzes volatile gases emitted by cancer cells in patient stool samples, supporting preventive diagnostics in a low-cost format. Operations are centered in Ferrara.

Scent's top competitors include IGM Biosciences, Check-Cap and Zymedi.

Scent has 1 investor. Key investors include UniCredit Start Lab.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available